Neuropharmacological studies of clustering molecules expressing in the excitatory synapses

兴奋性突触中表达的聚类分子的神经药理学研究

基本信息

  • 批准号:
    11470025
  • 负责人:
  • 金额:
    $ 9.22万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2001
  • 项目状态:
    已结题

项目摘要

A human homologue to the discs large (dlg) tumor suppresser protein, NE-dlg (neuronal and endocrine-dlg) has been cloned and characterized (K. Makino et al., Oncogene, 14, 2425, 1997). NE-dlg, also named SAP102, interacts with the NMDA receptor 2B (NR2B) to cluster the receptors in the postsynaptic density. We first documented that NE-dlg interacts with calmodulin and PSD-95 in vitro (J. Biol. Chem., 274, 5782, 1999). We also found an interacting protein, p51-Nedasin, in the brain. The P51-Nedasin interferes the association between NE-dlg and NR2B (J. Biol. Chem. 274, 32204, 1999). We next demonstrated in vitro and in situ phosphorylation of NE-dlg by CaM kinase II in the postsynaptic density fractions and in cultured rat hippocampal neurons. An increased phosphorylation of NE-dlg was also observed following hippocampal long-term potentiation. The increased phosphorylation was prevented by treatment with KN93, a CaM kinase inhibitor but not by protein kinase C inhibitors. We assessed the functional relevance of NE-dlg phosphorylation. CaM kinase Il-dependent NE-dlg phosphorylation prevented its binding to NR2B but promoted the accumulation of NR2B and NR1 in the postsynaptic density. As concerning the cytoplasmic localization of NE-dlg, the phosphorylation of NE-dlg by CaM kinase II is possibly involved in the transport of NR2B and/or NR1 into the postsynaptic density. We recently found that CaM kinase II is also involved in transport of dopamine D2 receptors from Golgi apparatus to the plasma membrane in the neurons, in which a scaffold protein like NE-dlg may underlie its transport mechanisms.
已经克隆并表征了椎间盘大(dlg)肿瘤抑制蛋白的人同源物NE-dlg(神经元和内分泌-dlg)(K. Makino等人,Oncogene,14,2425,1997)。NE-dlg,也称为SAP 102,与NMDA受体2B(NR2B)相互作用以使受体聚集在突触后密度中。我们首先证明了NE-dlg与钙调蛋白和PSD-95在体外相互作用(J. Biol. Chem.,274,5782,1999)。我们还在大脑中发现了一种相互作用的蛋白质,p51-Nedasin。P51-Nedasin干扰NE-dlg和NR2B之间的结合(J.Biol.Chem.274,32204,1999)。接下来,我们证明了在体外和原位磷酸化NE-dlg的钙调素激酶II在突触后密度组分和培养的大鼠海马神经元。在海马长时程增强后也观察到NE-dlg磷酸化增加。用CaM激酶抑制剂KN 93处理可阻止磷酸化增加,但蛋白激酶C抑制剂不能。我们评估了NE-dlg磷酸化的功能相关性。CaM激酶II依赖的NE-dlg磷酸化阻止其与NR2B结合,但促进NR2B和NR1在突触后致密物中的积累。关于NE-dlg的胞质定位,CaM激酶II对NE-dlg的磷酸化可能参与NR2B和/或NR1向突触后致密物的转运。我们最近发现,CaM激酶II也参与多巴胺D2受体从高尔基体转运到神经元的质膜,其中支架蛋白如NE-dlg可能是其转运机制的基础。

项目成果

期刊论文数量(172)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
H.Kanasaki, K.Fukunaga, K.Takahashi, K.Miyazaki and E.Miyamoto: "Mitogenactivated protein kinase activation by stimulation with thyrotropin-releasing hormone in rat pituitary GH3 cells."Biol.Reprod.. 61. 319-325 (1999)
H.Kanasaki、K.Fukunaga、K.Takahashi、K.Miyazaki 和 E.Miyamoto:“通过在大鼠垂体 GH3 细胞中用促甲状腺素释放激素刺激来激活丝裂原活化蛋白激酶。”Biol.Reprod.. 61. 319-325 (
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M Morioka, K. Fukunaga, Y. Kai, T. Todaka, S. Yano, J. Hamada, E. Miyamoto and Y. Ushio: "Intravenously injected FK506 failed to inhibit hippocampal calcineurin"Biochem. Biophys. Res. Commun.. 286. 802-806 (2001)
M Morioka、K. Fukunaga、Y. Kai、T. Todaka、S. Yano、J. Hamada、E. Miyamoto 和 Y. Ushio:“静脉注射 FK506 未能抑制海马神经钙蛋白”Biochem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
J.Kasahara: "Activation of Ca^<2+>/calmodulin-dependent protein kinase IV in cultured rat hippocampal neurons"J. Neurosci. Res.. 59. 594-600 (2000)
J.Kasahara:“培养的大鼠海马神经元中Ca^2/钙调蛋白依赖性蛋白激酶IV的激活”J。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K. Fukunaga and E. Miyamoto: "A working model of CaM kinase II activity in hippocampal long-term potentiation and memory"Neurosci. Res.. 38. 3-17 (2000)
K. Fukunaga 和 E. Miyamoto:“海马长时程增强和记忆中 CaM 激酶 II 活性的工作模型”Neurosci。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
I.Munir: "Mitogen-activated protein kinase activation and regulation of cyclooxygenase 2 expression by platelet-activating factor and hCG in human endometrial adenocarcinoma cell line HEC-1B"J. Reprod. Fertil.. 117. 49-59 (1999)
I.Munir:“人子宫内膜腺癌细胞系 HEC-1B 中丝裂原激活蛋白激酶的激活以及血小板激活因子和 hCG 对环氧合酶 2 表达的调节”J。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FUKUNAGA Kohji其他文献

FUKUNAGA Kohji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FUKUNAGA Kohji', 18)}}的其他基金

Role of fatty acid-binding protein in the brain vulnerability in schizophrenia
脂肪酸结合蛋白在精神分裂症大脑脆弱性中的作用
  • 批准号:
    22659012
  • 财政年份:
    2010
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Drug development targeting for regeneration of neurovascular units in neurodegenerative disorders
针对神经退行性疾病中神经血管单元再生的药物开发
  • 批准号:
    22390109
  • 财政年份:
    2010
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of novel neuroprotective drugs targeting for neurovascular unit therapy.
开发针对神经血管单元治疗的新型神经保护药物。
  • 批准号:
    19390150
  • 财政年份:
    2007
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Drug development by signal transduction therapy in the ischemic brain injury.
通过信号转导疗法治疗缺血性脑损伤的药物开发。
  • 批准号:
    14370035
  • 财政年份:
    2002
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Working mechanism of Ca^<2+>/calmodulin-dependent protein kinase II in synaptic plasticity
Ca^2/钙调蛋白依赖性蛋白激酶II在突触可塑性中的作用机制
  • 批准号:
    09670096
  • 财政年份:
    1997
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular pharmacological studies on the expression of synaptic plasticity
突触可塑性表达的分子药理学研究
  • 批准号:
    04670124
  • 财政年份:
    1992
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Pharmacological studies of calmodulin-dependent tau factor phosphorylation in cultured cerebellar granule cells.
培养小脑颗粒细胞中钙调蛋白依赖性 tau 因子磷酸化的药理学研究。
  • 批准号:
    02671056
  • 财政年份:
    1990
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Investigating IQGAP1, a scaffold protein, in liver biology and Hepatocellular Carcinoma to overcome barriers in in vivo models
研究肝脏生物学和肝细胞癌中的支架蛋白 IQGAP1,以克服体内模型中的障碍
  • 批准号:
    10370768
  • 财政年份:
    2023
  • 资助金额:
    $ 9.22万
  • 项目类别:
Systems-level characterization of scaffold protein signalling networks
支架蛋白信号网络的系统级表征
  • 批准号:
    DP220103638
  • 财政年份:
    2022
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Discovery Projects
Regulation of bipolar myosin filaments by the giant scaffold protein obscurin
巨型支架蛋白暗蛋白对双极肌球蛋白丝的调节
  • 批准号:
    RGPIN-2016-06793
  • 财政年份:
    2021
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Discovery Grants Program - Individual
Role of the Ankyrin-B scaffold protein in cardiomyocyte development
锚蛋白 B 支架蛋白在心肌细胞发育中的作用
  • 批准号:
    550271-2020
  • 财政年份:
    2020
  • 资助金额:
    $ 9.22万
  • 项目类别:
    University Undergraduate Student Research Awards
Development of fuctional molecular recognition elements utilizing a highly stable cushioning scaffold protein
利用高度稳定的缓冲支架蛋白开发功能性分子识别元件
  • 批准号:
    19K05166
  • 财政年份:
    2019
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Evaluation of circadian scaffold protein for diurnal localization of membrane transporter
昼夜节律支架蛋白对膜转运蛋白昼夜定位的评价
  • 批准号:
    19K23832
  • 财政年份:
    2019
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Regulation of bipolar myosin filaments by the giant scaffold protein obscurin
巨型支架蛋白暗蛋白对双极肌球蛋白丝的调节
  • 批准号:
    RGPIN-2016-06793
  • 财政年份:
    2019
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Discovery Grants Program - Individual
Unravelling the structural biology of a hypoxia scaffold protein using novel NMR approaches
使用新型 NMR 方法揭示缺氧支架蛋白的结构生物学
  • 批准号:
    2117702
  • 财政年份:
    2018
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Studentship
Regulation of bipolar myosin filaments by the giant scaffold protein obscurin
巨型支架蛋白暗蛋白对双极肌球蛋白丝的调节
  • 批准号:
    RGPIN-2016-06793
  • 财政年份:
    2018
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Discovery Grants Program - Individual
The XPA scaffold protein in Nucleotide Excision Repair
核苷酸切除修复中的 XPA 支架蛋白
  • 批准号:
    10733350
  • 财政年份:
    2018
  • 资助金额:
    $ 9.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了